Trial Profile
Open-label, Single-arm, Phase IV, Multicenter Trial to Explore the Immunogenicity of the Liquid Formulation of Saizen in Subjects With Adult Growth Hormone Deficiency (AGHD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Somatotropin deficiency
- Focus Pharmacodynamics
- Sponsors Merck KGaA
- 27 Feb 2018 Results published in the Journal of Endocrinological Investigation
- 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society
- 28 Jul 2016 Status changed from active, no longer recruiting to completed.